56
Heijinen, M. L., Van Amelsvoort, J. M., Deurenberg, P., & Beynen, A. C. (1996). Neither raw nor
retrograded resistant starch lowers fasting serum cholesterol concentration in healthy normolipededemic subjects. American Journal of Clinical Nutrition, 64(3), 312–318.
Higgins, J. A. & Brown, I. L. (2013). Resistant starch: a promising dietary agent for the prevention/
treatment of inflammatory bowel disease and bowel cancer. Current opinion in gastroenterology, 29(2): 190–194.
Jenkins, D. J., Vuksan, V., Kendall, C. W., Wursch, P., Jeffcoat, R., Waring, S., Mehling, C. C.,
Vidgen, E., Augustin, L. S. & Wong, E. (1998). Physiological effects of resistant starches on
fecal bulk, short chain fatty acids, blood lipids and glycemic index. Journal of the American
College of Nutrition, 17(6): 609–616.
Jyoshna, E. & Hymavathi, T. V. (2017). Review of studies on effect of resistant starch supplementation on glucose and insulin. Journal of Pharmacognosy and Phytochemistry, 6(3), 55–58.
Kalmokoff, M., Zwicker, B., O’hara, M., Matias, F., Green, J., Shastri, P., Green‐Johnson, J. &
Brooks, S. P. J. (2013). Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability. Journal of
applied microbiology, 114(5): 1516–1528.
Kovatcheva‐Datchary, P., Egert, M., Maathuis, A., Rajilić‐Stojanović, M., De Graaf, A.A., Smidt,
H., De Vos, W. M. & Venema, K. (2009). Linking phylogenetic identities of bacteria to starch
fermentation in an in vitro model of the large intestine by RNA‐based stable isotope probing.
Environmental microbiology, 11(4): 914–926.
Leeman, A. M., Karlsson, M. E., Eliasson, A. C. & Björck, I.M. (2006). Resistant starch formation
in temperature treated potato starches varying in amylose/amylopectin ratio. Carbohydrate
Polymers, 65(3), 306–313.
Leitch, E. C. M., Walker, A. W., Duncan, S. H., Holtrop, G. & Flint, H. J. (2007). Selective colonization of insoluble substrates by human faecal bacteria. Environmental microbiology, 9(3):
667–679.
Levrat, M. A., Moundras, C., Younes, H., Morand, C., Demigné, C. & Rémésy, C. (1996).
Effectiveness of resistant starch, compared to guar gum, in depressing plasma cholesterol and
enhancing fecal steroid excretion. Lipids, 31(10): 1069–1075.
Liu, R. & Xu, G. (2008). Effects of resistant starch on colonic preneoplastic aberrant crypt foci in
rats. Food and chemical toxicology, 46(8): 2672–2679.
Lopez, H. W., Levrat-Verny, M. A., Coudray, C., Besson, C., Krespine, V., Messager, A., Demigné,
C. & Rémésy, C. (2001). Class 2 resistant starches lower plasma and liver lipids and improve
mineral retention in rats. The Journal of nutrition, 131(4): 1283–1289.
Luckett, C.R., Wang, Y. J. (2012). Application of enzyme-treated corn starches in breakfast cereal
coating. J Food Sci. 77(8), 1750–3841.
Lunn, J., Buttriss J. L. (2007). Carbohydrates and dietary fibre. Journal compilation. British
Nutrition Foundation Nutrition Bulletin, 32, 21–64.
Maggio, C. A., & Pi-Sunyer, F. X. (2003). Obesity and type 2 diabetes. Endocrinology and
Metabolism Clinics of North America, 32(4), 805–822, viii.
M. Chandalia, A. Garg, D. Lutjohann, N. (2000) Engl. J. Med. 48, 342, 1392–1398.
Martinez, I., Kim, J., Duffy, P. R., Schlegel, V. L., & Walter, J. (2010). Resistant starch type 2 and
4 have different effects on the composition of the focal microbiota in human subject. PLoS
One, 5(11), e15046.
Marteau, P. R., de Vrese M., Cellier C. J., Schrezenmeir J. (2001). Protection from gastrointestinal
diseases with the use of Probiotics. Am. J. Clin. Nutr. (Suppl.) 73,430–436.
Martínez, I., Kim, J., Duffy, P. R., Schlegel, V. L. & Walter, J. (2010). Resistant starches types 2
and 4 have differential effects on the composition of the fecal microbiota in human subjects.
PloS one, 5(11), e15046.
Mathe, D., Riottot, M., Rostaqui, N. (1993). Effect of amylo-maize starch on plasma lipoproteins
of lean and obese zucker rats. Journal of Clinical Biochemistry and Nutrition. 14, 17–21.
Mauro, M. O., Monreal, M. T. F. D., Silva, M., Pesarini, J. R., Mantovani, M. S., Ribeiro, L. R.,
Dichi, J. B., Carreira, C. M. & Oliveira, R. J. (2013). Evaluation of the antimutagenic and anticarcinogenic effects of inulin in vivo. Genetics and Molecular Research, 12(3): 2281–2293.
G. Akhtar et al.
Heijinen, M. L., Van Amelsvoort, J. M., Deurenberg, P., & Beynen, A. C. (1996). Neither raw nor
retrograded resistant starch lowers fasting serum cholesterol concentration in healthy normolipededemic subjects. American Journal of Clinical Nutrition, 64(3), 312–318.
Higgins, J. A. & Brown, I. L. (2013). Resistant starch: a promising dietary agent for the prevention/
treatment of inflammatory bowel disease and bowel cancer. Current opinion in gastroenterology, 29(2): 190–194.
Jenkins, D. J., Vuksan, V., Kendall, C. W., Wursch, P., Jeffcoat, R., Waring, S., Mehling, C. C.,
Vidgen, E., Augustin, L. S. & Wong, E. (1998). Physiological effects of resistant starches on
fecal bulk, short chain fatty acids, blood lipids and glycemic index. Journal of the American
College of Nutrition, 17(6): 609–616.
Jyoshna, E. & Hymavathi, T. V. (2017). Review of studies on effect of resistant starch supplementation on glucose and insulin. Journal of Pharmacognosy and Phytochemistry, 6(3), 55–58.
Kalmokoff, M., Zwicker, B., O’hara, M., Matias, F., Green, J., Shastri, P., Green‐Johnson, J. &
Brooks, S. P. J. (2013). Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability. Journal of
applied microbiology, 114(5): 1516–1528.
Kovatcheva‐Datchary, P., Egert, M., Maathuis, A., Rajilić‐Stojanović, M., De Graaf, A.A., Smidt,
H., De Vos, W. M. & Venema, K. (2009). Linking phylogenetic identities of bacteria to starch
fermentation in an in vitro model of the large intestine by RNA‐based stable isotope probing.
Environmental microbiology, 11(4): 914–926.
Leeman, A. M., Karlsson, M. E., Eliasson, A. C. & Björck, I.M. (2006). Resistant starch formation
in temperature treated potato starches varying in amylose/amylopectin ratio. Carbohydrate
Polymers, 65(3), 306–313.
Leitch, E. C. M., Walker, A. W., Duncan, S. H., Holtrop, G. & Flint, H. J. (2007). Selective colonization of insoluble substrates by human faecal bacteria. Environmental microbiology, 9(3):
667–679.
Levrat, M. A., Moundras, C., Younes, H., Morand, C., Demigné, C. & Rémésy, C. (1996).
Effectiveness of resistant starch, compared to guar gum, in depressing plasma cholesterol and
enhancing fecal steroid excretion. Lipids, 31(10): 1069–1075.
Liu, R. & Xu, G. (2008). Effects of resistant starch on colonic preneoplastic aberrant crypt foci in
rats. Food and chemical toxicology, 46(8): 2672–2679.
Lopez, H. W., Levrat-Verny, M. A., Coudray, C., Besson, C., Krespine, V., Messager, A., Demigné,
C. & Rémésy, C. (2001). Class 2 resistant starches lower plasma and liver lipids and improve
mineral retention in rats. The Journal of nutrition, 131(4): 1283–1289.
Luckett, C.R., Wang, Y. J. (2012). Application of enzyme-treated corn starches in breakfast cereal
coating. J Food Sci. 77(8), 1750–3841.
Lunn, J., Buttriss J. L. (2007). Carbohydrates and dietary fibre. Journal compilation. British
Nutrition Foundation Nutrition Bulletin, 32, 21–64.
Maggio, C. A., & Pi-Sunyer, F. X. (2003). Obesity and type 2 diabetes. Endocrinology and
Metabolism Clinics of North America, 32(4), 805–822, viii.
M. Chandalia, A. Garg, D. Lutjohann, N. (2000) Engl. J. Med. 48, 342, 1392–1398.
Martinez, I., Kim, J., Duffy, P. R., Schlegel, V. L., & Walter, J. (2010). Resistant starch type 2 and
4 have different effects on the composition of the focal microbiota in human subject. PLoS
One, 5(11), e15046.
Marteau, P. R., de Vrese M., Cellier C. J., Schrezenmeir J. (2001). Protection from gastrointestinal
diseases with the use of Probiotics. Am. J. Clin. Nutr. (Suppl.) 73,430–436.
Martínez, I., Kim, J., Duffy, P. R., Schlegel, V. L. & Walter, J. (2010). Resistant starches types 2
and 4 have differential effects on the composition of the fecal microbiota in human subjects.
PloS one, 5(11), e15046.
Mathe, D., Riottot, M., Rostaqui, N. (1993). Effect of amylo-maize starch on plasma lipoproteins
of lean and obese zucker rats. Journal of Clinical Biochemistry and Nutrition. 14, 17–21.
Mauro, M. O., Monreal, M. T. F. D., Silva, M., Pesarini, J. R., Mantovani, M. S., Ribeiro, L. R.,
Dichi, J. B., Carreira, C. M. & Oliveira, R. J. (2013). Evaluation of the antimutagenic and anticarcinogenic effects of inulin in vivo. Genetics and Molecular Research, 12(3): 2281–2293.
G. Akhtar et al.